In this study, CTCs were classified into EMT subtypes using the CanPatrol system, and the expression of the molecular marker L1CAM was assessed to systematically evaluate their relationship with lymph node metastasis in breast cancer. This evidence concerns the gene L1CAM and breast cancer.